The personalized medicine and organization of geriatric care of population
- Authors: Belushkina N.N.1,2, Chemezov A.S.1, Paltsev M.A.1,2
- Affiliations:
- The Federal State Budget Educational Institution of Higher Education “The M. V. Lomonosov Moscow State University”
- The Federal State Budget Institution of Science “The N. M. Emanuel Institute of Biochemical Physics” of the Russian Academy of Sciences
- Issue: Vol 27, No 3 (2019)
- Pages: 227-230
- Section: Articles
- URL: https://journal-nriph.ru/journal/article/view/91
- DOI: https://doi.org/10.32687/0869-866X-2019-27-3-227-230
- Cite item
Abstract
Full Text
About the authors
N. N. Belushkina
The Federal State Budget Educational Institution of Higher Education “The M. V. Lomonosov Moscow State University”; The Federal State Budget Institution of Science “The N. M. Emanuel Institute of Biochemical Physics” of the Russian Academy of Sciences
Email: belushkina@rambler.ru
A. S. Chemezov
The Federal State Budget Educational Institution of Higher Education “The M. V. Lomonosov Moscow State University”
M. A. Paltsev
The Federal State Budget Educational Institution of Higher Education “The M. V. Lomonosov Moscow State University”; The Federal State Budget Institution of Science “The N. M. Emanuel Institute of Biochemical Physics” of the Russian Academy of Sciences
References
- Walko C. M., McLeod H. L. Personalizing Medicine in Geriatric Oncology. J. Clin. Oncol. 2014;32(24):2581-6. doi: 10.1200/JCO.2014.55.9047
- Roger V. L. Epidemiology of heart failure. Circ. Res. 2013;113:646-59.
- Белушкина Н. Н., Чемезов А. С., Пальцев М. А. Персонализированная медицина: от идеи до внедрения в практическое здравоохранение. Молекулярная медицина. 2018;16(3):9-15. doi: 10.29296/24999490-2018-03-02.
- Hermansson J., Kahan T. Systematic review of validity assessments of framingham risk score results in health economic modelling of lipid-modifying therapies in Europe. Pharmaco Economics. 2018;36:205-13. doi: 10.1007/s40273-017-0578-1
- Wu I-C., Lin C-C., Chao A., Hsiung C. A. Emerging roles of frailty and inflammaging in risk assessment of age-related chronic diseases in older adults: the intersection between aging biology and personalized medicine. BioMedicine. 2015;5(1):1-10.
- McVeigh T. P., Kerin M. J. Clinical use of the Oncotype DX genomic test to guide treatment decisions for patients with invasive breast cancer. Breast Cancer - Targets and Therapy. 2017;9:393-400. doi: 10.2147/BCTT.S109847
- Lopez-Otin C., Blasco M. A., Partridge L., Errano M., Kroemer G. The hallmarks of aging. Cell. 2013;153:1194-217.